← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2007Last known activity
Jan 25, 2018
Acquired by LabCorp on May 1, 2001
Timeline
1980s
- Jun 1, 1982
ViroMed— Founded
2000s
- May 1, 2001
LabCorp— Acquired By
Drugs by trial phase (3 distinct, 13 trials)
Indications
Studied for
- Amyotrophic Lateral Sclerosis
- Arterial Occlusive Diseases
- Coronary Artery Disease
- Diabetic Foot
- Diabetic Neuropathies
- Foot Ulcer
- Granuloma
- Granulomatous Disease, Chronic
- Heart Diseases
- Infarction
- Ischemia
- Motor Neuron Disease
- Myocardial Infarction
- Myocardial Ischemia
- Pain
- Peripheral Arterial Disease
- Peripheral Nervous System Diseases
- Peripheral Vascular Diseases
- Sclerosis
- Ulcer
- Vascular Diseases
Recent trials (13)
- NCT03404024Lead sponsorPhase 2Jan 25, 2018
- NCT03363165CollaboratorPhase 2Jan 1, 2018
- NCT02563522Lead sponsorPhase 3Dec 1, 2016
- NCT02427464Lead sponsorPhase 3Apr 1, 2016
- NCT01002495Lead sponsorPhase 1/Phase 2Mar 1, 2015
- NCT02039401Lead sponsorPhase 1/Phase 2Feb 1, 2014
- NCT01475786Lead sponsorPhase 2Aug 1, 2012
- NCT01548378CollaboratorPhase 2Mar 1, 2012
- NCT01064440Lead sponsorPhase 2Mar 1, 2010
- NCT01002235Lead sponsorPhase 1/Phase 2Feb 1, 2010
- NCT00696124Lead sponsorPhase 1Mar 1, 2007
- NCT00778882Lead sponsorPhase 1/Phase 2Jan 1, 2007
- NCT01422772Lead sponsorPhase 1Jan 1, 2007
Details
- Founded
- Burlington, NC, US Jun 1, 1982
- Last known activity
- Jan 25, 2018